Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ C5009947/?report=reader!5009947!27683536     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       EJIFCC 2016 ; 27 (3): 224-37 Nephropedia Template TP {{tp|p=27683536|t=2016. Soluble ST2 and Galectin-3: What We Know and Don?t Know Analytically |pdf=|usr=}}{{27683536}} gab.com Text Soluble ST2 and Galectin-3: What We Know and Don t Know Analytically JO: EJIFCC http://www.kidney.de/pget.php?&tw=1&pmid=27683536 #FOAvip The proteins soluble ST2 (sST2) and galectin-3 are currently gaining mounting interest as candidate biomarkers in cardiac disease. Both, sST2 and galectin-3 have been included in the 2013 ACCF/AHA guideline for additive risk stratification of patients with acute and chronic heart failure. The aim of this review is to provide information on analytical considerations of measuring circulating sST2 and galectin-3 including knowledge on in vitro stability, biological variation and reference ranges of both analytes. Twit Text FOAVip Soluble ST2 and Galectin-3: What We Know and Don t Know Analytically ????EJIFCC http://www.kidney.de/pget.php?&tw=1&pmid=27683536 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27683536 #FOAvip English Wikipedia <ref>{{Cite pmid|27683536}}</ref> Soluble ST2 and Galectin-3: What We Know and Don?t Know Analytically #MMPMID27683536 Mueller T; Dieplinger B EJIFCC 2016[Jul]; 27 (3): 224-37 PMID27683536show ga The proteins soluble ST2 (sST2) and galectin-3 are currently gaining mounting interest as candidate biomarkers in cardiac disease. Both, sST2 and galectin-3 have been included in the 2013 ACCF/AHA guideline for additive risk stratification of patients with acute and chronic heart failure. The aim of this review is to provide information on analytical considerations of measuring circulating sST2 and galectin-3 including knowledge on in vitro stability, biological variation and reference ranges of both analytes. äSoluble ST2 and Galectin-3: What We Know and Don?t Know Analytically (epmc).pdf DeepDyve Pubget Overpricing